MDMA-assisted therapy training for practitioners

Learn to safely and effectively guide clients through therapeutic MDMA experiences.

Program At A Glance

Clinical MDMA-assisted therapy

A two-part, 122-hour training pathway for clinicians preparing to safely offer MDMA-assisted psychotherapy, grounded in trauma care, patient advocacy, and supervised experiential learning.

For
Clinicians & allied professionals
Mental health, medical, and supportive care professionals preparing to work with patients in medical need.
Length
122 hours
Didactic seminars, required readings and webinars, experiential learning, and clinical supervision across 12 units.
Format
Two-part pathway
Part 1 is the core curriculum (Units 1 to 10), online or in person. Part 2 adds the experiential and supervision pathway (Units 11 and 12).
Availability
Small, limited cohorts
Online and in-person didactic options, plus an in-person intensive with experiential pathways in British Columbia.
Overview

What this training prepares you for

You will learn to deliver MDMA-assisted psychotherapy for trauma and complex mental health conditions, from assessment and preparation through dosing and long-term integration.

What You'll Learn
  • Assess and advocate for patients in medical need using TheraPsil's protocols and inclusion criteria.
  • The legal landscape for psychedelic medicine in Canada, including Health Canada approvals and SAP applications.
  • MDMA neuropharmacology, medication interactions, and contraindications for safe, trauma-focused care.
  • Preparing the therapy space, selecting music, and the roles of primary and secondary therapists in dosing sessions.
  • Facilitating preparation, dosing, and integration with safety, trauma awareness, and long-term follow-up.
  • Equity, identity, and implicit bias, and the challenges faced by marginalized communities in MDMA therapy.
Curriculum overview
Who Can Apply

Practitioners preparing for MDMA-assisted psychotherapy across mental health, medical, and supportive care contexts, including:

  • Psychologists, counsellors, psychotherapists, social workers, and psychiatric nurses
  • Physicians, nurses, and nurse practitioners
  • Naturopathic doctors, paramedics, and death doulas
  • Recognized spiritual or pastoral counsellors in trauma-informed or end-of-life care

Preference is given to applicants with prior psychedelic training and those who have completed TheraPsil's psilocybin fundamentals.

Training FAQ
Why Train

Why train with TheraPsil

Built on years of patient advocacy and clinical work, this program bridges emerging science, the realities of access in Canada, and the skills clinicians need to safely offer MDMA-assisted psychotherapy.

Trauma-focused and patient-centred

Learn an MDMA-assisted psychotherapy protocol that centres complex trauma, patient rights, and careful clinical assessment, informed by current research and real patient stories.

Canada's first MDMA-specific training

Train in a program dedicated specifically to MDMA-assisted psychotherapy, developed for real-world clinical and regulatory contexts, with direct links to patient advocacy.

Experiential pathways and referrals

Move from didactic learning into supervised experiential routes and clinical supervision, with access to our Psychedelic Therapy Directory and a growing community of colleagues.

Tuition

Choose the format that fits

All fees are in Canadian dollars and subject to tax. Cohorts run online and in person through the year.

Online or in-person didactic
$3,800

The core curriculum, Units 1 to 10. Choose live online over two weekends or a four-day in-person seminar (cohort dependent). Includes small-group learning, required readings and webinars, with experiential and supervision pathways available separately.

In-person intensive
$5,499 · $5,199 early bird

A six-day intensive in British Columbia that includes experiential pathways. Supervision for Unit 12 is arranged separately, with individual and group options through our training portal.

Limited bursaries (typically $500) are available for each cohort, with priority for BIPOC, LGBTQ+, and other marginalized practitioners. Indicate financial need in your application or email support@therapsil.ca.
Prescriber or part of a treatment team? The MDMA prescriber training is a shorter, focused course on pharmacology, medication interactions, and access pathways. Explore prescriber training
Inside The Training

MDMA training in action

A CBC News feature filmed during the inaugural MDMA training in British Columbia, documenting supervised, trauma-informed learning and why this work calls for careful training and clear standards.

A Trauma-Informed, Experiential Approach

The segment captures clinicians learning within a supervised, relational setting, alongside expert commentary on why MDMA-assisted psychotherapy calls for careful training, ethical boundaries, and accountability.

Experiential Learning

Training beyond the classroom

Our approach includes experiential education as one part of preparing clinicians for psychedelic-assisted therapy. Supervised experiential pathways are discussed with eligible applicants as part of the broader training journey.

Clinicians in TheraPsil MDMA training Group learning during MDMA training Training environment at TheraPsil TheraPsil MDMA training cohort
How It Works

Steps to join the program

Three steps, with a real person behind every email. If you are unsure which option fits, our team will help you decide.

1

Submit your online application

Share your professional background, current practice, and preferred cohort, and note your interest in the online didactic, the in-person intensive, and experiential options.

2

Meet with our training team

Join a short interview to confirm entrance requirements, clarify your goals, and discuss timelines for didactic training, experiential routes, and supervision.

3

Confirm your place and prepare

Once accepted, you register and join our Community of Care and Practice, where pre-reading, webinars, logistics, and community engagement live ahead of your cohort.

Subscribe to our newsletter!

Be the first to hear about new trainings, legal updates, and community events. Join TheraPsil’s newsletter and stay connected to Canada’s psychedelic advocacy and training community.